福斯塔马提尼布的营销后安全监测:利用FAERS数据库进行的观察性药监测研究

福斯塔马提尼布的营销后安全监测:利用FAERS数据库进行的观察性药监测研究

相关实验视频

Updated: Jun 18, 2025

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

10:33

An Automated Radiosynthesis of [⁶⁸Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

745

Wei Wei¹, Ying-Tao Bai¹, En Chang¹

¹Department of Pharmacy, People's Hospital of Zhongjiang County, Deyang, Sichuan, China.

Expert opinion on drug safety

|July 30, 2024

概括

这项研究分析了fostamatinib的现实世界不良事件 (AEs),这是FDA批准的治疗慢性免疫血栓塞缩症 (ITP) 的药物. 它确定了已知的副作用,并标记了潜在的新出现的安全问题,包括脑血栓症等严重事件.

科学领域:

药物监督药物监督药物监督
血液学血液学血液学
药品安全药品安全

背景情况:

福斯塔马提尼布是一种FDA批准的口服腺氨酸激酶 (SYK) 抑制剂,用于治疗其他治疗不耐用的慢性免疫血栓缩 (ITP).
对于fostamatinib的全面真实世界的安全数据是有限的.
了解不良事件 (AE) 对于安全的临床使用至关重要.

研究的目的:

为了调查与 fostamatinib 相关的现实世界的不良事件 (AEs).
使用FDA不良事件报告系统 (FAERS) 数据库识别潜在的安全问题.
为管理fostamatinib安全性的临床医生和药剂师提供证据.

主要方法:

追溯分析FAERS数据库 (2019-2023) 对于与 fostamatinib 相关的报告.
使用不成比例分析:ROR,PRR,BCPNN和MGPS来检测AE信号.
评估了23个已识别的AE信号.

主要成果:

一致的副作用包括高血压,血压升高,肝酶升高和腹.
检测到意想不到的严重副作用:脑血栓和死软组织感染.
与fostamatinib相关的副作用的发病时间中位数为86天.

结论:

该研究确定了在现实世界中使用fostamatinib时可能出现的安全问题.
这些发现强调了对特定严重的副作用的临床警的必要性.
为医疗保健专业人员管理 ITP 患者使用 fostamatinib 提供必要的安全证据.

关键词:

AE信号是AE的信号.公平的人是公平的.在ITP中,ITP是ITP.不成比例性分析分析这里是 fostamatinib 的原产地.药物监督和药物监督

更多相关视频

FIBS-enabled Noninvasive Metabolic Profiling

09:16

FIBS-enabled Noninvasive Metabolic Profiling

Published on: February 3, 2014

9.9K

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

8.3K

相关概念视频

01:19

Pharmacovigilance

805

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

805

01:25

Drug Regulation

1.3K

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

1.3K

01:11

Clinical Trials: Overview

2.9K

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...